Bsfllp Description


Print this page

Melissa Willett

Senior Attorney
Washington, DC

t: 202-274-1110
f: 202.237.6131
Download vCard

Areas of Practice



Class Actions


University of the District of Columbia David A. Clarke Law School, J.D., 1998

Campbell University, B.B.A., Business Administration, 1986


District of Columbia

Since joining the firm in 1998, Ms. Willett's main practice areas have focused on complex commercial litigation, plaintiffs' antitrust matters and class actions. 

Significant matters in which Ms. Willett has been actively involved include: 

  • In re Vitamins Antitrust Litigation, a case in which the firm uncovered an international conspiracy and represented purchasers of a range of vitamins in pursuing price fixing and market allocation claims, resulting in settlement totaling more than $1 billion.
  • Animal Science Products v. Mitsui & Co., an international cartel case, resulting in a jury verdict for the class of $49.5 million (before trebling).
  • The first class actions uncovering cartels in China responsible for exporting products to the United States, including with respect to the vitamin C industry.
  • In re First Databank Antitrust Litigation (firm selected as co-lead counsel).
  • In Re Municipal Derivatives Antitrust Litigation (firm selected as co-lead counsel).
  • In re Polyurethane Foam Antitrust Litigation (firm selected as co-lead counsel).

Prior to entering law school Ms. Willett worked in the financial industry.  After her first year of law school, Ms. Willett was selected to be a Child Advocate for the Charles County Legal Aid Bureau.  During her third year of law school, she worked with former Special Assistant Attorney General for the State of Maryland, Edward C. Digges, who successfully argued before the Supreme Court in Virginia v. Maryland regarding the ownership of the Potomac River.

Related News

BSF Wins Historic Verdict in Antitrust Case against Chinese Vitamin C Cartel (03.14.2013)

The BSF Report: Spring 2013 (03.08.2013)

Unprecedented Settlement Reached in Antitrust Class Action against Chinese Producers of Vitamin C (06.27.2012)